News
Hemogenyx Pharma Plc - Directorate Change
RNS Number: 5280 J Hemogenyx Pharmaceuticals PLC 03 April 2018 Hemogenyx Pharmaceuticals Plc. Anti-TNF therapy is the world's largest drug class with more than US $36 bn in sales. Remicade was the main driver of the $4.9 billion acquisition of Centocor by Johnson and Johnson in 1999, and is still J&J's best selling drug. Since 2012 Anti-TNF therapy has become...
RNS Number: 5280 J Hemogenyx Pharmaceuticals PLC 03 April 2018 Hemogenyx Pharmaceuticals Plc. Anti-TNF therapy is the world's largest drug class with more than US $36 bn in sales. Remicade was the main driver of the $4.9 billion acquisition of Centocor by Johnson and Johnson in 1999, and is still J&J's best selling drug. Since 2012 Anti-TNF therapy has become...